First Line Management of Adult Diabetic Ketoacidosis Patients
Journal Title: The Egyptian Journal of Hospital Medicine - Year 2017, Vol 67, Issue 0
Abstract
Abstract Background:Diabetic Ketoacidosis (DKA) is a hyperglycemic crisis that can occur in patients with both type 1 and 2 diabetes mellitus. It is a medical emergency with a significant morbidity and mortality. It is however a potentially reversible condition in case an emergency and immediate medical attention, prompt recognition, diagnosis and treatment were provided. Aim of the Study:was to leverage the current research data in order to construct a treatment guideline for diabetic ketoacidosis in the emergency department. Methods:A literature search was carried out on MEDLINE (including MEDLINE in-process), CINAHL,Embase and the Cochrane Library. Databases using “diabetic ketoacidosis” as a MeSH heading and as textword. High yield journals were also hand searched. Findings:The initial treatment phase aims to restore circulating volume, reduce blood glucose levels, to correct any electrolyte imbalances and to reduce ketone levels which in turn corrects the acidosis. Evidence also showed that there is no need for insulin bolus prior to starting an insulin drip in the treatment of diabetic ketoacidosis. Also, using beta-hydroxybutyrate at presentation can expedite diagnosis and therefore treatment. Implementing treatment guidelines into the emergency department may help expedite diagnosis and treatment. Conclusion:Prompt first line management of DKA is the most critical stage to profoundly reduce morbidity and mortality rates of this potentially fatal crisis. It’s therefore crucial to follow the evidence-based guidelines and DKA protocol in the emergency department to expedite diagnosis, guide treatment, and improve continuity of care between the emergency department and the ICU as well as improving the clinical outcomes of patients with DKA. Initially, this will improve outcomes by decreasing the delay until treatment is initiated andprovide a continuum of treatment between the emergency department and the intensive care unit. Furthermore, the healthcare providersmust ensure that they have the ability to provide support and education to people at risk of developing DKA and those that have had an episode of DKA by spreading awareness and education to help reduce both the initial occurrence and recurrence of this often preventable life-threatening condition.
Authors and Affiliations
Amirah Ali Alshammari1; Louai M Alahdal2; JenanTajuddin Jawi3; Hanouf Abdullah Alnofaie4; Nourah Ali Aldossari5; Hala Mohammad Abdulaziz Alassaf1 1Hail University
Keywords
Related Articles
- EP ID EP499232
- DOI -
- Views 111
- Downloads 0
Role of folic acid deficiency as a possible risk factor for erectile dysfunction
Background: erectile dysfunction (ED) is the persistent inability to attain or maintain an erection. ED affects millions of men worldwide. The pathophysiology of ED includes vasculogenic, neurogenic, hormonal, anatomical...
Comparative Study between Effect of Clomiphene Citrate, Tamoxifen and Letrozole on Endometrial Thickness in Induction of Ovulation in Patient with Polycystic Ovarian Syndrome
<strong>Background: </strong>Infertility is the inability of a married couple to conceive within one year in spite of regular marital life. Globally 10-15% of the married couples are experiencing this problem. CC is non-...
Correlation of Average Retinal Nerve Fiber Layer Thickness Using OCT with The Perimetric Staging in Primary Open Angle Glaucoma
<span>Background: </span><span>Primary open angle glaucoma (POAG) is the most common type of glaucoma which is considered chronic progressive optic neuropathy, accompanied by a characteristic cupping and atrophy of the o...
The Possible Radio Protective Role of Aphanizomenon Flos-Aquae (AFA) on Heart of The Adult Male Albino Rats
<span>Aim of the work: </span><span>this study demonstrated the drastic effects of ionizing radiation on the heart tissue of the adult male albino rats and the possible radio protective role of AFA extract.<br /> </span>...
Levonorgestrel Releasing IUS (Metraplant E) in the Management of Copper IUD Related Heavy Painful Menstrual Loss
<span>Background: </span><span>the LNG-IUD was first introduced in Finland in 1990 and is currently marketed in most European countries and in the US since 2000</span><span>. </span><span>The Levonorgestrel IUD is approv...